Gene Logic's Compound Selection partners have access to the entire DRS Technology Platform to assist in identifying optimal candidates to move forward into preclinical or clinical development. The program can help discriminate and prioritize drug candidates by discerning compounds with superior activity and flag potential variable responder genotypes to individual drug metabolizing and transporters.